Class information for:
Level 1: SMAD//SMAD4//SNON

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1682 2457 50.2 95%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
880 10788 HEREDITARY HEMORRHAGIC TELANGIECTASIA//ENDOGLIN//TGF BETA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SMAD Author keyword 78 24% 11% 281
2 SMAD4 Author keyword 76 40% 6% 147
3 SNON Author keyword 59 81% 1% 35
4 SMAD7 Author keyword 50 41% 4% 95
5 ARKADIA Author keyword 34 93% 1% 13
6 DEV SIGNALLING Address 32 60% 1% 35
7 C SKI Author keyword 32 78% 1% 21
8 SMADS Author keyword 29 31% 3% 79
9 SMAD2 Author keyword 26 32% 3% 67
10 DPC4 Author keyword 19 49% 1% 28

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SMAD 78 24% 11% 281 Search SMAD Search SMAD
2 SMAD4 76 40% 6% 147 Search SMAD4 Search SMAD4
3 SNON 59 81% 1% 35 Search SNON Search SNON
4 SMAD7 50 41% 4% 95 Search SMAD7 Search SMAD7
5 ARKADIA 34 93% 1% 13 Search ARKADIA Search ARKADIA
6 C SKI 32 78% 1% 21 Search C+SKI Search C+SKI
7 SMADS 29 31% 3% 79 Search SMADS Search SMADS
8 SMAD2 26 32% 3% 67 Search SMAD2 Search SMAD2
9 DPC4 19 49% 1% 28 Search DPC4 Search DPC4
10 SKI 18 34% 2% 44 Search SKI Search SKI

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MAD RELATED PROTEIN 198 68% 7% 174
2 TUMOR SUPPRESSOR SMAD4 110 81% 3% 67
3 C SKI 78 78% 2% 52
4 DPC4 GENE 73 64% 3% 72
5 SMAD PROTEINS 71 30% 8% 201
6 DPC4 59 52% 3% 80
7 V SKI 57 95% 1% 19
8 SNON 43 69% 2% 37
9 FYVE DOMAIN PROTEIN 30 55% 2% 38
10 TUMOR SUPPRESSORS SMAD2 27 92% 0% 11

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Mechanisms of TGF-beta signaling from cell membrane to the nucleus 2003 2799 133 72%
Smad-dependent and Smad-independent pathways in TGF-beta family signalling 2003 2195 97 65%
TGF beta signalling in context 2012 360 145 38%
Smad transcription factors 2005 1134 249 59%
TGF beta in cancer 2008 1255 116 27%
Specificity and versatility in TGF-beta signaling through Smads 2005 913 195 62%
Non-Smad pathways in TGF-beta signaling 2009 418 90 58%
New insights into TGF-beta-Smad signalling 2004 576 65 60%
SMAD4 and its role in pancreatic cancer 2015 3 91 42%
Non-Smad signaling pathways 2012 127 85 53%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DEV SIGNALLING 32 60% 1.4% 35
2 FUTURE PROGRAM 17 52% 0.9% 23
3 CELL REGULAT CARCINOGENESIS 12 18% 2.4% 59
4 GI DEV BIOL 6 80% 0.2% 4
5 MODELING BIOL NETWORKS 6 80% 0.2% 4
6 CELLULAR BIOCHEM H3 4 75% 0.1% 3
7 MED ONCOLCANC NEW JERSEY 4 75% 0.1% 3
8 CANC GENET DIGEST DIS DEV MOL BIOL 3 57% 0.2% 4
9 MOL MED PATHOGENESIS 3 35% 0.3% 7
10 PHARMACOL CHINESE VET MED 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000233806 ALK5 INHIBITOR//CELL BASED LUCIFERASE REPORTER ASSAY//TGFB1
2 0.0000173841 WWP1//SMURF1//CKIP 1
3 0.0000140921 TGF BETA RECEPTORS//TGF BETA RECEPTOR//MED MED CELL BIOL
4 0.0000139841 HUMAN TOXICOL PROGRAM//PROGRAM FREE RAD RADIAT BIOL//BIOQUIM BIOQUIM BIOL MOL
5 0.0000114077 GREMLIN//AFFILIATED XIANG YA HOSP//BMP9
6 0.0000106250 TWISTED GASTRULATION//TOLLOID//CHORDIN
7 0.0000100041 CTHRC1//COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1//CAROTID ARTERY RESTENOSIS
8 0.0000093393 PHENOTYPE INDUCTION//PHOSPHORYLATED SMAD2//SMAD UBIQUITINATION REGULATORY FACTOR 2
9 0.0000081361 ENDOGLIN//CD105//TRC105
10 0.0000076903 CRIPTO 1//TUMOR GROWTH TOR SECT//CRIPTO